Technicals for Alembic Pharmaceuticals Limited
The current state of the AROON is neutral for APLLTD, providing no...
The current state of the AROON is neutral for APLLTD, providing no...
APLLTD's current ratio, being 1.593, demonstrates that the company has the liquidity...
The list of all important regulatory filings for Alembic Pharmaceuticals Limited which...
An analysis of JPMorgan Chase's $105 billion 2026 expense guidance, exploring its...
An investor-oriented article synthesising corporate leaders’ optimism for 2025 and the top...
An investor-focused analysis of major shifts in the financial services landscape as...
| Published | Title | Summary |
|---|---|---|
| 2025-07-03 17:21:18 | Acquisition-XBRL | Alembic Pharmaceuticals Limited has informed the Exchange regarding Acquisition... |
| 2025-01-22 16:54:37 | Board Meeting Intimation | Alembic Pharmaceuticals Limited has informed the Exchange about Board Meeting... |
| 2024-10-18 12:04:54 | Board Meeting Intimation | ALEMBIC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
| 2024-07-25 16:51:48 | Board Meeting Intimation | ALEMBIC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
| 2024-05-09 14:06:37 | Dividend | Alembic Pharmaceuticals Limited has informed the Exchange that Board of... |
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Lists of companies in NSE500 with the best and the worst technicals...
An article analysing how new U.S. tariff policies are contributing to economic...
An article exploring Oracle’s latest quarterly results that reveal a significant AI...
An in-depth article analysing the Federal Reserve’s December 2025 rate cut and...